Powered by
Tags
Government

Overview

We are an attractive location to undertake clinical trials.
Our regulatory and tax environment, plus access to world-class researchers and clinicians, creates an ideal market for prototyping, testing, conducting clinical trials and manufacturing. With modern translational facilities and fast, pragmatic regulatory pathways, our infrastructure is a commercially focused platform for growth.
By choosing Queensland, you can increase the speed of your product R&D. Including southern hemisphere sites means you can access all-year-round recruitment of patients suffering from seasonal ailments, including influenza and allergies, including those diagnosed with respiratory and tropical diseases.
Each year, Queensland conducts thousands of clinical trials across hundreds of sites around the state. In 2022-2023, there were more than 320 new clinical trials conducted in Queensland Health, which is the largest provider of clinical trials in the state.
Queensland is leading the country with teletrial capability. Teletrials is a proven model that uses telecommunication technology to connect clinical trial clusters to improve access to, and participation in clinical trials for regional, rural and remote Australians.
Queensland is part of a nationwide approach which has embraced a fast and pragmatic regulatory pathway for conducting clinical trials. The regulatory framework allows rapid clinical trials start-up through streamlined processes under the Clinical Trials Notification (CTN) scheme administered by the Therapeutic Goods Administration (TGA).
Australian clinical trial data is accepted by international regulatory agencies including the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
There has never been a better time to come to Queensland!

Delegates

Denise-Johnston-Headshot.jpg
Denise Johnston
Executive Director, Strategic Industry Development
Michele-Bauer.jpg
Michele Bauer
Deputy Director-General, State Development